Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M McCune

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|July 1, 1976
Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigenR E Humphreys, J M McCune, L Chess, et al.
Nature Medicine|June 1, 2001
Impaired replication of protease inhibitor-resistant HIV-1 in human thymusC A Stoddart, T J Liegler, F Mammano, et al.
Nature Medicine|January 3, 2001
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasisL A Napolitano, R M Grant, S G Deeks, et al.
Advances in Neuroimmunology|January 1, 1994
Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infectionL G Epstein, T A Cvetkovich, E S Lazar, et al.
Nature Medicine|January 12, 1999
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humansM Hellerstein, M B Hanley, D Cesar, et al.
The Journal of Infectious Diseases|December 23, 1999
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapyK Y Smith, H Valdez, A Landay, et al.
Journal of Virology|August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymusR D Berkowitz, A B van't Wout, N A Kootstra, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320C A Stoddart, L Rabin, M Hincenbergs, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2002
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNAR A Neese, L M Misell, S Turner, et al.
Journal of Virology|November 13, 1998
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivoR D Berkowitz, S Alexander, C Bare, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|July 1, 1976
Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigenR E Humphreys, J M McCune, L Chess, et al.
Nature Medicine|June 1, 2001
Impaired replication of protease inhibitor-resistant HIV-1 in human thymusC A Stoddart, T J Liegler, F Mammano, et al.
Nature Medicine|January 3, 2001
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasisL A Napolitano, R M Grant, S G Deeks, et al.
Advances in Neuroimmunology|January 1, 1994
Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infectionL G Epstein, T A Cvetkovich, E S Lazar, et al.
Nature Medicine|January 12, 1999
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humansM Hellerstein, M B Hanley, D Cesar, et al.
The Journal of Infectious Diseases|December 23, 1999
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapyK Y Smith, H Valdez, A Landay, et al.
Journal of Virology|August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymusR D Berkowitz, A B van't Wout, N A Kootstra, et al.
Antimicrobial Agents and Chemotherapy|August 4, 1998
Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320C A Stoddart, L Rabin, M Hincenbergs, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2002
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNAR A Neese, L M Misell, S Turner, et al.
Journal of Virology|November 13, 1998
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivoR D Berkowitz, S Alexander, C Bare, et al.
Pageof 9